CRISPR And CRISPR-Associated Genes Market Size Worth USD USD 3.73 billion by 2032.

 

CRISPR/CRISPR-associated Genes Market was USD 1.56 billion in 2021. CAGR of 16.67% is projected to increase to USD 3.73 billion by 2032.

A rise in COVID-19 diagnostic test demand is expected to make the COVID-19 market more attractive. Sherlock Biosciences announced in May 2020 that it had been granted an emergency use authorization by the United States Food and Drug Administration for its Sherlock SARS CoV-2 kit, which is used to detect COVID-19. The Sherlock CRISPR SARS CoV-2 kit could deliver results in under an hour. This is a much shorter time than any other available tests. Researchers from the University of California San Francisco and UC Berkeley announced a collaboration to develop a CRISPR-based test for COVID-19. The new test will use a simple smartphone camera as a microscope capable of detecting coronavirus genetic material. CRISPR and CRISPR-associated (Cass) Genes are expected to benefit from such initiatives.

To know about more drivers and challenges – Download a PDF sample@ https://market.us/report/crispr-and-crispr-associated-genes-market/request-sample/

CRISPR is a major contributor to the market’s expansion. It has been widely used in genome editing and other biotechnological applications. CRISPR’s popularity has increased over the years, from its discovery as a tool in genetics to help develop adaptive immunity in bacteria to its current status as a highly effective and accessible tool. CRISPR technology is driving advancements in genome editing across medicine and biotechnology. This has allowed scientists to conduct more research in these areas through faster and better genome editing worldwide. CRISPR technology has been in demand because of its accessibility to vectors quickly and cheaply and the subsequent next-generation tools offered by Addgene (a nonprofit plasmid repository). According to “The CRISPR Journal,” Addgene has distributed more than 100,000 CRISPR vectors to more than 3400 laboratories across the globe. Additionally, more than 6,300 CRISPR-related plasmids have been developed by more than 330 research laboratories and are now part of Addgene’s library. These companies should expect a positive market change by taking the initiative and engaging in collaborative activities.

Market growth is driven by increasing investments by biotechnology companies and non-profit organizations in research and developmental programs. CRISPR Therapeutics for HIV treatment announced in December 2020 that they had been awarded a grant from Bill & Melinda Gates Foundation. Mammoth Biosciences, which received the latest Series B funding round, announced it had received USD 45 million in January 2020. The funding would be used to develop further CRISPR diagnostics for the company and the next-generation CRISPR products.

Drivers:

  • Market growth is driven by advances in the pharmaceutical and biopharmaceutical industries.
  • CRISPR is being used more widely, and the prevalence of chronic and genetic disorders is increasing.
  • Market growth will also be boosted by the increasing use of genome editing technology.

Restraints:

  • The market will be constrained by intense competition and high costs associated with the study.

Key Market Trends

The Market’s Largest Genome Engineering Segment

The growing adoption of gene editing techniques for germline alterations and therapeutic development is responsible for the largest market share. CRISPR genome engineering uses a nuclease called CRISPR-associated Protein 9 (Cas9) that interacts with small guide RNAs (gRNAs). This allows for the cleavage of DNA in a sequence-specific way upstream from any adjacent protospacer motif.

Many Cas proteins can bind to nucleic acid, making the CRISPR tool a powerful tool for genome engineering. Cas 9 is one of the most frequently used Cas proteins for regulation and genome engineering. Developing other programmable nucleases has greatly accelerated the process of genome engineering. These include zinc-finger nucleases and transcription activator-like effects or nucleases. Its simplicity is CRISPR greatest advantage over other genome editing techniques. CRISPR genes can be used directly in embryos. This reduces the time it takes to modify target genes compared to other gene-targeting technologies that rely on embryonic stem cells (ESC). CRISPR editing can be used to modify a gene or other region of the genome. It is relatively cost-effective. Improved bioinformatics tools allow for identifying the best sequences for designing guide RNAs, and optimization of experimental conditions allows for robust procedures that can successfully introduce the desired mutation. These factors will drive significant growth in the genome engineering segment.

Key Market Segments

Type

  • Genome Editing
  • Genetic engineering
  • GRNA Database/Gene Library
  • CRISPR Plasmid
  • Human Stem Cells
  • Genetically Modified Organisms/Crops
  • Cell Line Engineering

Application

  • Biotechnology Companies
  • Pharmaceutical Companies
  • Academic Institutes
  • Research and Development Institutes

Key Market Players included in the report:

  • Thermo Fisher Scientific
  • Editas Medicine
  • Caribou Biosciences
  • CRISPR therapeutics
  • Intellia therapeutics
  • Cellectis
  • Horizon Discovery Plc
  • Sigma Aldrich
  • Precision Biosciences
  • Genscript
  • Sangamo Biosciences
  • Lonza Group Limited
  • Integrated DNA Technologies
  • New England Biolabs
  • Origene Technologies

Frequently Asked Questions

What is the study period of this market?

What is the growth rate of the Global CRISPR and CRISPR-Associated Genes Market?

Which region has the highest growth rate in the Global CRISPR and CRISPR-Associated Genes Market?

Which region has the largest share in the Global CRISPR and CRISPR-Associated Genes Market?

Who are the key players in the Global CRISPR And CRISPR-Associated Genes Market?

Related Reports

Viral Vectors and Plasmid DNA Manufacturing Market Outlook |[BENEFITS] Industry Statistics 2031

CRISPR Gene Editing Market [+PESTLE Analysis] | Highlights Analysis till 2031

CRISPR Technology Market in Manufacturing | Supply and Demand by 2031 [PDF]

Genomics Market Unidentified Segments|[RISING TODAY] The Biggest Opportunity In 2022

Synthetic Biology Market [+PORTER’S Five Force Analysis] | Statistics and Forecast to 2031

About Market.us

Market.US (Powered by Prudour Private Limited) specializes in in-depth market research and analysis and has been proving its mettle as a consulting and customized market research company, apart from being a much sought-after syndicated market research report providing firm.

Contact Details:

Global Business Development Team – Market.us

Address: 420 Lexington Avenue, Suite 300 New York City, NY 10170, United States

Phone: +1 718 618 4351 (International), Phone: +91 78878 22626 (Asia)

Email: [email protected]

WHAT TO TAKE AWAY FROM THIS ARTICLE:

  • CRISPR’s popularity has increased over the years, from its discovery as a tool in genetics to help develop adaptive immunity in bacteria to its current status as a highly effective and accessible tool.
  • Sherlock Biosciences announced in May 2020 that it had been granted an emergency use authorization by the United States Food and Drug Administration for its Sherlock SARS CoV-2 kit, which is used to detect COVID-19.
  • Researchers from the University of California San Francisco and UC Berkeley announced a collaboration to develop a CRISPR-based test for COVID-19.

About the author

Avatar of Linda Hohnholz

Linda Hohnholz

Editor in chief for eTurboNews based in the eTN HQ.

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x
Share to...